A synthetic cyclic peptide analog of alpha-MSH that activates melanocortin receptors in the central nervous system. Registered as a pharmaceutical in the US (bremelanotide/Vyleesi) for HSDD.
Peptalis — for laboratory research use only. Not for human use.